2011

Success of the Simplified Cash Tender Offer for the Shares and bons the souscription d’actions of Novagali Pharma SA by Santen Pharmaceutical Co., Ltd

Santen Pharmaceutical Co., Ltd. (« Santen ») and Novagali Pharma SA (« Novagali ») announced today the success of the simplified cash tender offer for the shares and bons de souscription d’actions (“BSAs”) of Novagali initiated by Santen.

The Autorité des Marchés Financiers (“AMF”) published today the results of the Offer which took place from December 2, 2011 to December 15, 2011 included. Over the course of the Offer, 7,545,247 shares, 700 2014 BSAs and 5,406 2019 BSAs have been tendered, for €6.15 per share, €4.03 per 2014 BSA and €2.75 per 2019 BSA.

[+] Previous page

Agenda

29 - 30 November 2012
World orphan Drug Congress: Geneva, Switzerland

11 - 13 September 2012
World Biosimilars Congress: Jumeirah Carlton Tower, London, UK

May 23, 24 & 25, 2012
14th Annual PHARMACEUTICAL CONFERENCE: Milano (Lake Maggiore), ITALY

21-22 May 2012
The 5th Annual European Life Science CEO Forum: Palm Beach County Convention Center, Florida

[+] Consult the agenda

In order to receive
Genopole^® press releases^®,
please provide your coordinates
to Press Service